Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 52

Sort by

Sort Order Select

Journal Articles

Abstract LB178: Neoplastic immune mimicry is a generalizable phenomenon in breast cancer and epithelial CD69 enables early tumor progression

Eric B. Berens, Sokchea Khou, Elaine Huang, Amber Hoffman, Briana Johnson, Nell Kirchberger, Sam Sivagnanam, Nicholas Calistri, Daniel Derrick, Tiera A. Liby, Ian C. McLean, Aryn A. Alanizi, E. Shelley Hwang, Pepper Schedin, Hugo Gonzalez, Zena Werb, Laura M. Heiser, Lisa M. Coussens

Cancer Res (2025) 85 (8_Supplement_2): LB178.

https://doi.org/10.1158/1538-7445.AM2025-LB178

Published: 25 April 2025

View articletitled, Abstract LB178: Neoplastic immune mimicry is a generalizable phenomenon in breast cancer and epithelial CD69 enables early tumor progression

Journal Articles

Correction: Quantitative Spatial Profiling of Immune Populations in Pancreatic Ductal Adenocarcinoma Reveals Tumor Microenvironment Heterogeneity and Prognostic Biomarkers

Haoyang Mi, Shamilene Sivagnanam, Courtney B. Betts, Shannon M. Liudahl, Elizabeth M. Jaffee, Lisa M. Coussens, Aleksander S. Popel

Cancer Res (2024) 84 (21): 3701.

https://doi.org/10.1158/0008-5472.CAN-24-2929

Published: 04 November 2024

View articletitled, Correction: Quantitative Spatial Profiling of Immune Populations in Pancreatic Ductal Adenocarcinoma Reveals Tumor Microenvironment Heterogeneity and Prognostic Biomarkers

Journal Articles

Abstract CT016: Immunomodulation of the tumor microenvironment of pancreatic ductal adenocarcinoma with histone deacetylase inhibition: Results of a phase 2 clinical trial of entinostat in combination with nivolumab

Cancer Res (2024) 84 (7_Supplement): CT016.

https://doi.org/10.1158/1538-7445.AM2024-CT016

Published: 05 April 2024

View articletitled, Abstract CT016: Immunomodulation of the tumor microenvironment of pancreatic ductal adenocarcinoma with histone deacetylase inhibition: Results of a phase 2 clinical trial of entinostat in combination with nivolumab

Journal Articles

Abstract LB224: Neoplastic immune mimicry potentiates breast cancer progression

Eric B. Berens, Sokchea Khou, Elaine Huang, Amber Hoffman, Briana Johnson, Zena Werb, Laura M. Heiser, Lisa M. Coussens

Cancer Res (2024) 84 (7_Supplement): LB224.

https://doi.org/10.1158/1538-7445.AM2024-LB224

Published: 05 April 2024

View articletitled, Abstract LB224: Neoplastic immune mimicry potentiates breast cancer progression

Journal Articles

Abstract 4027: From tumor progression to therapeutic control: Combinatorial targeting of immune vulnerabilities in TNBC

Amanda Poissonnier, Eivind Valen Egeland, Wesley Horton, Shamilene Sivagnanam, Orian Stapleton, Rossin Erbe, Nell Kirchberger, Konjit Betre, Alyza Skaist, Ludmila Danilova, Andrew Fields, Peter Ordentlich, Andrew C. Adey, Elana J. Fertig, Lisa M. Coussens

Cancer Res (2024) 84 (6_Supplement): 4027.

https://doi.org/10.1158/1538-7445.AM2024-4027

Published: 22 March 2024

View articletitled, Abstract 4027: From tumor progression to therapeutic control: Combinatorial targeting of immune vulnerabilities in TNBC

Journal Articles

Abstract A061: A novel genetically engineered mouse model of Myc-driven pancreatic cancer recapitulates phenotypic heterogeneity, metastasis, and therapy resistance seen in clinical populations

Cancer Res (2024) 84 (2_Supplement): A061.

https://doi.org/10.1158/1538-7445.PANCA2023-A061

Published: 16 January 2024

View articletitled, Abstract A061: A novel genetically engineered mouse model of Myc-driven pancreatic cancer recapitulates phenotypic heterogeneity, metastasis, and therapy resistance seen in clinical populations

Journal Articles

Abstract C087: Window-of-opportunity trial of metastatic pancreatic cancer reveals mechanisms of response to targeting RAS signaling

Motoyuki Tsuda, Colin J. Daniel, Carl Pelz, Sam Sivagnanam, Dove Keith, Christopher L. Corless, Koei Chin, Lisa M. Coussens, Jonathan R. Brody, Charles D. Lopez, Gordon B. Mills, Rosalie C. Sears

Cancer Res (2024) 84 (2_Supplement): C087.

https://doi.org/10.1158/1538-7445.PANCA2023-C087

Published: 16 January 2024

View articletitled, Abstract C087: Window-of-opportunity trial of metastatic pancreatic cancer reveals mechanisms of response to targeting RAS signaling

Journal Articles

Abstract 4916: Spatial analysis of local drug induced changes in tumor microenvironment predicts effective treatment combinations in breast cancer

Zuzana Tatarova, Dylan C. Blumberg, Gordon B. Mills, Lisa M. Coussens, Oliver Jonas, Joe W. Gray

Cancer Res (2023) 83 (7_Supplement): 4916.

https://doi.org/10.1158/1538-7445.AM2023-4916

Published: 04 April 2023

View articletitled, Abstract 4916: Spatial analysis of local drug induced changes in tumor microenvironment predicts effective treatment combinations in breast cancer

Journal Articles

Abstract 6618: Longitudinal, multimodal profiling of metastatic ER+ breast cancer on CDK4/6 inhibitor therapy

Allison L. Creason, Julian Egger, Cameron Watson, Shamilene Sivagnanam, Jia-Ren Lin, Koei Chin, Peter K. Sorger, Lisa M. Coussens, Zahi I. Mitri, Joe W. Gray, Gordon B. Mills, Jeremy Goecks

Cancer Res (2023) 83 (7_Supplement): 6618.

https://doi.org/10.1158/1538-7445.AM2023-6618

Published: 04 April 2023

View articletitled, Abstract 6618: Longitudinal, multimodal profiling of metastatic ER+ breast cancer on CDK4/6 inhibitor therapy

Journal Articles

Abstract 3473: High throughput screening of combination therapies to improve response to checkpoint inhibitors in solid tumors using a myelomonocytic and T cell co-culture assay

Sushil Kumar, Dhanir Tailor, Arpit Dheeraj, Wenqi Li, Jee Min Lee, Kirsten Stefan, Dylan Nelson, Shivaani Kummar, Lisa M. Coussens, Sanjay V. Malhotra

Cancer Res (2023) 83 (7_Supplement): 3473.

https://doi.org/10.1158/1538-7445.AM2023-3473

Published: 04 April 2023

View articletitled, Abstract 3473: High throughput screening of combination therapies to improve response to checkpoint inhibitors in solid tumors using a myelomonocytic and T cell co-culture assay

Journal Articles

Abstract 5572: A COX-2-based pro-tumourigenic inflammatory signature predicts poor outcome in early-stage non-small cell lung cancer

Victoria Fife, Matthew Roberts, Christian P. Bromley, Derrick Morgan, Sophie Atkinson, Cong Zhou, Anshuman Chaturvedi, Steven Bagley, Garry Ashton, Lisa M. Coussens, Philip A. Crosbie, Caroline Dive, Elaine Kilgour, Santiago Zelenay

Cancer Res (2023) 83 (7_Supplement): 5572.

https://doi.org/10.1158/1538-7445.AM2023-5572

Published: 04 April 2023

View articletitled, Abstract 5572: A COX-2-based pro-tumourigenic inflammatory signature predicts poor outcome in early-stage non-small cell lung cancer

Journal Articles

Abstract 4293: Strategies and resources for applying a quantitative multiplex IHC imaging workflow to characterize immune contexture in solid tumors

Shamilene Sivagnanam, Courtney M. Betts, Nell Kirchberger, Konjit Betre, Lisa M. Coussens

Cancer Res (2023) 83 (7_Supplement): 4293.

https://doi.org/10.1158/1538-7445.AM2023-4293

Published: 04 April 2023

View articletitled, Abstract 4293: Strategies and resources for applying a quantitative multiplex IHC imaging workflow to characterize immune contexture in solid tumors

Journal Articles

Abstract 4164: Relieving immune suppressive pathways in breast cancer to improve outcomes

Amanda Poissonnier, Eivind Valen Egeland, Rossin Erbe, Wesley Horton, Ana Howells-Ferreira, Shamilene Sivagnanam, Nell Kirchberger, Dhaarini Murugan, Andrew Fields, Peter Ordentlich, Andrew C. Adey, Elana J. Fertig, Lisa M. Coussens

Cancer Res (2023) 83 (7_Supplement): 4164.

https://doi.org/10.1158/1538-7445.AM2023-4164

Published: 04 April 2023

View articletitled, Abstract 4164: Relieving immune suppressive pathways in breast cancer to improve outcomes

Journal Articles

Quantitative Spatial Profiling of Immune Populations in Pancreatic Ductal Adenocarcinoma Reveals Tumor Microenvironment Heterogeneity and Prognostic Biomarkers

Haoyang Mi, Shamilene Sivagnanam, Courtney B. Betts, Shannon M. Liudahl, Elizabeth M. Jaffee, Lisa M. Coussens, Aleksander S. Popel

Cancer Res (2022) 82 (23): 4359–4372.

https://doi.org/10.1158/0008-5472.CAN-22-1190

Published: 02 December 2022

View articletitled, Quantitative Spatial Profiling of Immune Populations in Pancreatic Ductal Adenocarcinoma Reveals Tumor Microenvironment Heterogeneity and Prognostic Biomarkers

Includes: Supplementary data

Journal Articles

Abstract A067: Myc drives phenotypic heterogeneity, metastasis, and therapy resistance in pancreatic ductal adenocarcinoma

Isabel A. English, Patrick J. Worth, Amy S. Farrell, Brittany L. Allen-Petersen, Vidhi Shah, Courtney Betts, Carl Pelz, Xiaoyan Wang, Colin J. Daniel, Mary C Thoma, Lisa M Coussens, Ellen M Langer, Rosalie C Sears

Cancer Res (2022) 82 (22_Supplement): A067.

https://doi.org/10.1158/1538-7445.PANCA22-A067

Published: 15 November 2022

View articletitled, Abstract A067: Myc drives phenotypic heterogeneity, metastasis, and therapy resistance in pancreatic ductal adenocarcinoma

Journal Articles

Abstract 880: MYC drives phenotypic heterogeneity, metastasis, and therapy resistance in pancreatic ductal adenocarcinoma

Isabel A. English, Patrick J. Worth, Amy S. Farrell, Brittany L. Allen-Petersen, Vidhi Shah, Courtney Betts, Carl Pelz, Xiaoyan Wang, Colin J. Daniel, Mary C. Thoma, Lisa M. Coussens, Ellen M. Langer, Rosalie C. Sears

Cancer Res (2022) 82 (12_Supplement): 880.

https://doi.org/10.1158/1538-7445.AM2022-880

Published: 15 June 2022

View articletitled, Abstract 880: MYC drives phenotypic heterogeneity, metastasis, and therapy resistance in pancreatic ductal adenocarcinoma

Journal Articles

Abstract 2149: Biomarker-driven selection of polyADP ribose polymerase inhibitors (PARPi)-based combination therapies in patients with metastatic triple negative breast cancer (mTNBC)

Zahi I. Mitri, Evthokia A. Hobbs, Shaun M. Goodyear, Jeong Youn Lim, Joanna Pucilowska, Brett Johnson, Allison L. Creason, Courtney Betts, Lisa M. Coussens, Shannon McWeeney, Christopher L. Corless, Joe W. Gray, Gordon B. Mills

Cancer Res (2022) 82 (12_Supplement): 2149.

https://doi.org/10.1158/1538-7445.AM2022-2149

Published: 15 June 2022

View articletitled, Abstract 2149: Biomarker-driven selection of polyADP ribose polymerase inhibitors (PARPi)-based combination therapies in patients with metastatic triple negative breast cancer (mTNBC)

Journal Articles

Abstract P5-13-05: Multiplex spatial systems analysis of responses to spatially separate nanoliter doses of drug predicts systemic immune-modulating combination treatments in breast cancer

Zuzana Tatarova, Dylan C Blumberg, Lisa M Coussens, Gordon B Mills, Oliver Jonas, Joe W Gray

Cancer Res (2022) 82 (4_Supplement): P5-13-05.

https://doi.org/10.1158/1538-7445.SABCS21-P5-13-05

Published: 15 February 2022

View articletitled, Abstract P5-13-05: Multiplex spatial systems analysis of responses to spatially separate nanoliter doses of drug predicts systemic immune-modulating combination treatments in breast cancer

Journal Articles

Abstract PO-061: Myc drives phenotypic heterogeneity, metastasis, and therapy resistance in pancreatic ductal adenocarcinoma

Isabel A. English, Patrick J. Worth, Amy T. Farrell, Brittany L. Allen-Petersen, Vidhi Shah, Courtney Betts, Xiaoyan Wang, Colin J. Daniel, Mary C. Thoma, Lisa M. Coussens, Ellen M. Langer, Rosalie C. Sears

Cancer Res (2021) 81 (22_Supplement): PO-061.

https://doi.org/10.1158/1538-7445.PANCA21-PO-061

Published: 15 November 2021

View articletitled, Abstract PO-061: Myc drives phenotypic heterogeneity, metastasis, and therapy resistance in pancreatic ductal adenocarcinoma

Journal Articles

Abstract CT005: T cell inflammation in the tumor microenvironment after agonist CD40 antibody: Clinical and translational results of a neoadjuvant clinical trial

Cancer Res (2021) 81 (13_Supplement): CT005.

https://doi.org/10.1158/1538-7445.AM2021-CT005

Published: 01 July 2021

View articletitled, Abstract CT005: T cell inflammation in the tumor microenvironment after agonist CD40 antibody: Clinical and translational results of a neoadjuvant clinical trial

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract LB178: Neoplastic immune mimicry is a generalizable phenomenon in breast cancer and epithelial CD69 enables early tumor progression

Correction: Quantitative Spatial Profiling of Immune Populations in Pancreatic Ductal Adenocarcinoma Reveals Tumor Microenvironment Heterogeneity and Prognostic Biomarkers

Abstract CT016: Immunomodulation of the tumor microenvironment of pancreatic ductal adenocarcinoma with histone deacetylase inhibition: Results of a phase 2 clinical trial of entinostat in combination with nivolumab

Abstract LB224: Neoplastic immune mimicry potentiates breast cancer progression

Abstract 4027: From tumor progression to therapeutic control: Combinatorial targeting of immune vulnerabilities in TNBC

Abstract A061: A novel genetically engineered mouse model of Myc-driven pancreatic cancer recapitulates phenotypic heterogeneity, metastasis, and therapy resistance seen in clinical populations

Abstract C087: Window-of-opportunity trial of metastatic pancreatic cancer reveals mechanisms of response to targeting RAS signaling

Abstract 4916: Spatial analysis of local drug induced changes in tumor microenvironment predicts effective treatment combinations in breast cancer

Abstract 6618: Longitudinal, multimodal profiling of metastatic ER+ breast cancer on CDK4/6 inhibitor therapy

Abstract 3473: High throughput screening of combination therapies to improve response to checkpoint inhibitors in solid tumors using a myelomonocytic and T cell co-culture assay

Abstract 5572: A COX-2-based pro-tumourigenic inflammatory signature predicts poor outcome in early-stage non-small cell lung cancer

Abstract 4293: Strategies and resources for applying a quantitative multiplex IHC imaging workflow to characterize immune contexture in solid tumors

Abstract 4164: Relieving immune suppressive pathways in breast cancer to improve outcomes

Quantitative Spatial Profiling of Immune Populations in Pancreatic Ductal Adenocarcinoma Reveals Tumor Microenvironment Heterogeneity and Prognostic Biomarkers

Abstract A067: Myc drives phenotypic heterogeneity, metastasis, and therapy resistance in pancreatic ductal adenocarcinoma

Abstract 880: MYC drives phenotypic heterogeneity, metastasis, and therapy resistance in pancreatic ductal adenocarcinoma

Abstract 2149: Biomarker-driven selection of polyADP ribose polymerase inhibitors (PARPi)-based combination therapies in patients with metastatic triple negative breast cancer (mTNBC)

Abstract P5-13-05: Multiplex spatial systems analysis of responses to spatially separate nanoliter doses of drug predicts systemic immune-modulating combination treatments in breast cancer

Abstract PO-061: Myc drives phenotypic heterogeneity, metastasis, and therapy resistance in pancreatic ductal adenocarcinoma

Abstract CT005: T cell inflammation in the tumor microenvironment after agonist CD40 antibody: Clinical and translational results of a neoadjuvant clinical trial

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only